MedMen Enterprises Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MedMen Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MMNFF, but not buy additional shares or sell existing shares.
View analyst ratings for MedMen Enterprises or view top-rated stocks.

Wall Street analysts have given MedMen Enterprises a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but MedMen Enterprises wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

MedMen Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, October 13th 2021.
View our earnings forecast for MedMen Enterprises.

MedMen Enterprises Inc. (OTCMKTS:MMNFF) announced its quarterly earnings results on Monday, February, 15th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.03.
View MedMen Enterprises' earnings history.

MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MMNFF shares have increased by 92.3% and is now trading at $0.2959.
View which stocks have been most impacted by COVID-19.

1 equities research analysts have issued twelve-month price targets for MedMen Enterprises' stock. Their forecasts range from $0.30 to $0.30. On average, they expect MedMen Enterprises' stock price to reach $0.30 in the next twelve months. This suggests a possible upside of 1.4% from the stock's current price.
View analysts' price targets for MedMen Enterprises or view top-rated stocks among Wall Street analysts.

Some companies that are related to MedMen Enterprises include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF).
View all of MMNFF's competitors.

MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."

Shares of MMNFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MMNFF stock can currently be purchased for approximately $0.30.

MedMen Enterprises employs 1,000 workers across the globe.

The official website for MedMen Enterprises is www.medmen.com.

MedMen Enterprises is headquartered at 10115 Jefferson Boulevard, Culver City, CA 90232.

MedMen Enterprises' mailing address is 10115 Jefferson Boulevard, Culver City, CA 90232. The company can be reached via phone at (855) 292-8399.